Heuking advises i-SOLUTIONS majority shareholder on sale to funds advised by Trill Impact

Funds advised by Trill Impact acquired majority stakes in Meona Group and i-SOLUTIONS Health GmbH including their subsidiaries with the objective of merging the two companies. A team led by Dr. Rainer Herschlein, Partner at Heuking Kühn Lüer Wojtek, and Benedikt Raisch, Salaried Partner at Heuking Kühn Lüer Wojtek, advised the majority shareholder of i-SOLUTIONS, a German family office, on the sale of the shares. The transaction is subject to merger control clearance by the German Federal Cartel Office. The intended merger of Meona and i-SOLUTIONS is considered a strong signal in the healthcare IT market.
 
i-SOLUTIONS Health GmbH offers solutions for patient management and billing in hospitals, laboratories, and radiology practices. The company’s holistic IT concepts include consulting, software, and service. 240 employees support some 880 installations across Europe.
 
Meona Group, with its Belgian subsidiary E.care, is a provider of software solutions supporting all workflows and requirements of modern everyday hospital life. Its product portfolio includes a specialized solution for ERs, comprehensive software for cytostatics production, and an intelligent pricing solution for prescriptions.
 
Private equity firm Trill Impact supports companies in Northern Europe that address social challenges in line with corporate sustainable development objectives. 

Counsel to the majority shareholder of i-SOLUTIONS Health GmbH
Heuking Kühn Lüer Wojtek:
Dr. Rainer Herschlein, LL.M. (Fordham University),
Benedikt Raisch, (both Lead, Corporate/M&A), both Stuttgart
Dr. Emanuel Teichmann (Corporate/M&A), Stuttgart
Dr. Stefan Bretthauer (Antitrust), Hamburg
Fabian G. Gaffron (Tax), Hamburg